Search PubMed⌕ Search

Biomedical subjects

J Foulds

Publications and source records attributed to J Foulds.

70 records · Page 4Linked to original sources
PubMed1978

Chromosomal location of a gene (nmpA) involved in expression of a major outer membrane protein in Escherichia coli.

The phenotypic expression of protein E, a recently described major outer membrane protein, is associated with a mutation at a locus on the Escherichia coli chromosome that we call nmpA. nmpA is located between rbsK and uncA at 82.7 min on the E. coli linkage map. The nmpA locus is also the site of the mutations which lead to the formation of major outer membrane proteins Ic or e. It is likely proteins E, Ic, and e are closely related or identical. The mutant nmpA allele is dominant.

Bacterial Proteins↗
PubMed1977

Envelope composition and antibiotic hypersensitivity of Escherichia coli mutants defective in phosphatidylserine synthetase.

Mutants of Escherichia coli K12, defective in phosphatidylserine synthetase (pss), can be isolated as temperature-sensitive, conditional lethals. When cultivated at intermediate temperatures (30 degrees), such mutants contain approximately 3 times more phosphatidylglycerol plus cardiolipin (and less phosphatidylethanolamine) than normal. We now wish to report that, under these conditions, the pss-8 mutant is hypersensitive to certain antibiotics, especially to streptomycin, kanamycin, and gentamicin, although also to ampicillin and novobiocin. At 30 degrees, the membrane protein and fatty acid composition of pss-8 is nearly normal, i.e. identical with an isogenic pss+ organism. Radiochemical labeling and bacteriophage growth studies show that lipopolysaccharide is also unaltered. Therefore, the antibiotic hypersensitivity of pss-8 differs from previously reported hypersensitivities, associated with lipopolysaccharide defects. These results suggest that the polar phospholipid headgroups may play an important role in maintaining the barrier function of the outer gramnegative membrane and that putative inhibitors of the phosphatidylserine synthetase might potentiate the action of numerous antibiotics currently in clinical use.

Anti-Bacterial Agents↗
PubMed1977

Purification of protein A, an outer membrane component missing in Escherichia coli K-12 ompA mutants.

Outer membrane materials prepared from an Escherichia coli ompA (tolG) strain do not contain one of the major outer membrane proteins found in ompA+ strains. This protein has been purified in high yield from detergent-solubilized cell envelope material prepared from an ompA+ strain by preparative electrophoresis in polyacrylamide gels containing sodium dodecyl sulfate. The purified protein is homogeneous in three electrophoretic systems, contains 2 mol of reducing sugar/mol of peptide and has alanine as the N-terminal amino acid. The amino acid composition is nearly identical to outer membrane protein II or B purified by others from incompletely solubilized cell envelope material. Thus, the fraction of outer membrane protein II or B that is difficult to solubilize is identical with the more readily solubilized fraction.

Amino Acids↗
PubMed1977

Escherichia coli K-12 tolF mutants: alterations in protein composition of the outer membrane.

Outer membrane materials prepared from three independently isolated spontaneous Escherichia coli tolF mutants contained no detectable protein Ia. The loss of this protein was nearly completely compensated for by an increase in other major outer membrane proteins, Ib and II. Thus, the major outer membrane proteins accounted for 40% of the total cell envelope protein in both tol+ and tolF strains. No changes were found in the levels of inner membrane proteins prepared from tolF strains when compared with similar preparations from the tol+ strain. Phage-resistant mutants were selected starting with a tolF strain by using either phage TuIb or phage PA2. These phage-resistant tolF strains contained neither protein Ia nor protein Ib. The mutation leading to the loss of protein Ib in these strains is independent of the tolF mutation and is located near malP on the E. coli genetic map.

Bacterial Outer Membrane Proteins↗
PubMed1976

TolF locus in Escherichia coli: chromosomal location and relationship to loci cmlB and tolD.

The tentative map position on the Escherichia coli chromosome of the tolF locus, determining tolerance to colicins A, E2, E3, K, and L, has been confirmed by three-point transduction. It lies between the aroA and pyrD loci at about 21 min on the linkage map of Bachmann et al. (1976). The cmlB locus, determining increased resistance to the antibiotics chloramphenicol and tetracycline, also lies in this region (Reeve, 1966). Phenotypic and genetic comparison of isogenic strains that carry a mutation in either the tolF or cmlB locus makes it likely that these loci are closely related or identical. The tolD locus determining tolerance to colicins E2 and E3 as well as increased resistance to antibiotics has been reported to be located close to the aroA locus as a result of conjugation experiments (Eriksson-Grennberg et al. 1965). However, tolD did not cotransduce with any of several loci in this region, indicating that the mutation is not located within the region of the genetic map corresponding to approximately 19 to 22.5 min.

Chromosome Mapping↗
PubMed1974

Mapping of the locus for Escherichia coli transfer ribonucleic acid nucleotidyltransferase.

cca Mutants of Escherichia coli K12 have altered levels of tRNA nucleotidyl-transferase activity. The cca locus has been located at minute 59.4 of the E. coli linkage map. It is cotransduced with tolC but not with argG, and is the earliest known marker transferred by Hfr strain KL14. The proximity of the tolC locus to the integrated sex factor in Hfr strain KL14 may be useful for mapping sex factor mutations by transduction.

Chromosome Mapping↗
PubMed1974

How am I doing?

Explore the source record for details and available documents.

England↗
PubMed1973

Characterization of Escherichia coli mutants tolerant to bacteriocin JF246: two new classes of tolerant mutants.

Several hundred independent bacteriocin-tolerant mutants have been isolated without mutagenesis from three strains of Escherichia coli. On the basis of patterns of sensitivity to eight different colicins, over 85% of these mutants could be grouped into four classes. Two classes of mutants, class A and class B, are equivalent to tolA and tolB type mutants. We found tolA and tolB mutants were sensitive to the antibiotic bacitracin. The other two classes of bacteriocin-tolerant mutants, class F and class G, are distinguished from other types of colicin-tolerant mutants on the basis of sensitivity to colicins, dyes, detergents, antibiotics, and chelating agents. The mutation in class F and class G mutants is located between 21 to 23 min on the E. coli chromosome. We propose to designate the loci of these mutations as tolF and tolG, respectively.

Anti-Bacterial Agents↗
PubMed1973

Your choice.

Explore the source record for details and available documents.

Home Care Services↗
PubMed1972

Purification and partial characterization of a bacteriocin from Serratia marcescens.

Bacteriocin JF246 has been purified from mitomycin C-induced Serratia marcescens cells by salt extraction, ammonium sulfate fractionation, and chromatography on QAE-Sephadex and SP-Sephadex. The purified material is homogeneous on polyacrylamide gel electrophoresis in the presence of 2% sodium dodecyl sulfate or 6 m urea. In the absence of these agents, the bacteriocin associates into aggregates which can be dissociated with 0.4 m NaCl. The bacteriocin is probably composed of a single subunit with a molecular weight of 64,000 daltons. Analytical studies show the bacteriocin to be essentially protein in nature containing less than one residue of glucose or phosphorus per 64,000 daltons.

Amino Acids↗
PubMed1971

Mode of action of a bacteriocin from Serratia marcescens.

The effects of bacteriocin JF246, produced by Serratia marcescens, on the incorporation of labeled leucine and thymidine, the synthesis of beta-galactosidase, the active transport of labeled leucine and alpha-methyl-d-glucoside, and the cellular levels of adenosine triphosphate (ATP) in Escherichia coli were studied. This bacteriocin strongly inhibited the incorporation of leucine and thymidine into protein and deoxyribonucleic acid, respectively, as well as the active transport of leucine. The accumulation of alpha-methyl-d-glucoside, which is mediated by a phosphoenolpyruvate-dependent phosphotransferase system, was not markedly inhibited. The level of ATP in bacteriocin-treated cells rapidly fell to 10 to 15% of the control value. However, the kinetics of inhibition of macromolecular synthesis by various levels of bacteriocin was not related to the kinetics of ATP decline.

Adenosine↗